2023
Baseline skin cytokine profiles determined by RNA in situ hybridization correlate with response to dupilumab in patients with eczematous dermatitis
Singh K, Valido K, Swallow M, Okifo K, Wang A, Cohen J, Damsky W. Baseline skin cytokine profiles determined by RNA in situ hybridization correlate with response to dupilumab in patients with eczematous dermatitis. Journal Of The American Academy Of Dermatology 2023, 88: 1094-1100. PMID: 36780951, DOI: 10.1016/j.jaad.2022.12.052.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, MonoclonalCytokinesDermatitis, AtopicEczemaHumansIn Situ HybridizationInterleukin-13Retrospective StudiesSeverity of Illness IndexTreatment OutcomeConceptsEczematous dermatitisHistologic featuresTreatment selectionType 1Type 3 inflammationInflammatory skin diseaseCertain histologic featuresSitu hybridization correlatesClinical responseNonresponder groupCytokine profileCytokine stainingAtopic dermatitisCytokine RNAEczematous disordersSitu hybridizationDupilumabIL13 expressionSkin diseasesType 2PatientsDermatitisNonrespondersMolecular heterogeneityImproved response
2018
Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers
Feng H, Cohen JM, Neimann AL. Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers. Journal Of Dermatological Treatment 2018, 30: 237-239. PMID: 30078341, DOI: 10.1080/09546634.2018.1508819.Peer-Reviewed Original Research